GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (STU:BSX) » Definitions » Cyclically Adjusted Price-to-FCF

Boston Scientific (STU:BSX) Cyclically Adjusted Price-to-FCF : 102.24 (As of May. 20, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Boston Scientific Cyclically Adjusted Price-to-FCF?

As of today (2024-05-20), Boston Scientific's current share price is €68.50. Boston Scientific's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €0.67. Boston Scientific's Cyclically Adjusted Price-to-FCF for today is 102.24.

The historical rank and industry rank for Boston Scientific's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

STU:BSX' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 11.49   Med: 61.47   Max: 105.51
Current: 103.22

During the past years, Boston Scientific's highest Cyclically Adjusted Price-to-FCF was 105.51. The lowest was 11.49. And the median was 61.47.

STU:BSX's Cyclically Adjusted Price-to-FCF is ranked worse than
83.9% of 236 companies
in the Medical Devices & Instruments industry
Industry Median: 44.395 vs STU:BSX: 103.22

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Boston Scientific's adjusted free cash flow per share data for the three months ended in Mar. 2024 was €-0.050. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €0.67 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Boston Scientific Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Boston Scientific's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boston Scientific Cyclically Adjusted Price-to-FCF Chart

Boston Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.00 61.93 64.47 69.11 79.41

Boston Scientific Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.28 79.72 75.49 79.41 94.71

Competitive Comparison of Boston Scientific's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Boston Scientific's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boston Scientific's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Cyclically Adjusted Price-to-FCF falls into.



Boston Scientific Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Boston Scientific's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=68.50/0.67
=102.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boston Scientific's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Boston Scientific's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.05/131.7762*131.7762
=-0.050

Current CPI (Mar. 2024) = 131.7762.

Boston Scientific Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.126 100.560 0.165
201409 0.167 100.428 0.219
201412 0.205 99.070 0.273
201503 -0.170 99.621 -0.225
201506 0.009 100.684 0.012
201509 0.224 100.392 0.294
201512 0.048 99.792 0.063
201603 0.037 100.470 0.049
201606 0.225 101.688 0.292
201609 -0.066 101.861 -0.085
201612 0.258 101.863 0.334
201703 -0.099 102.862 -0.127
201706 0.134 103.349 0.171
201709 0.211 104.136 0.267
201712 0.341 104.011 0.432
201803 0.017 105.290 0.021
201806 -0.297 106.317 -0.368
201809 0.237 106.507 0.293
201812 -0.069 105.998 -0.086
201903 0.163 107.251 0.200
201906 0.072 108.070 0.088
201909 0.231 108.329 0.281
201912 0.409 108.420 0.497
202003 -0.115 108.902 -0.139
202006 0.110 108.767 0.133
202009 0.293 109.815 0.352
202012 0.287 109.897 0.344
202103 0.123 111.754 0.145
202106 0.311 114.631 0.358
202109 0.212 115.734 0.241
202112 0.131 117.630 0.147
202203 -0.119 121.301 -0.129
202206 0.133 125.017 0.140
202209 0.210 125.227 0.221
202212 0.394 125.222 0.415
202303 0.045 127.348 0.047
202306 0.286 128.729 0.293
202309 0.313 129.860 0.318
202312 0.428 129.419 0.436
202403 -0.050 131.776 -0.050

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Boston Scientific  (STU:BSX) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Boston Scientific Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Boston Scientific's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Boston Scientific (STU:BSX) Business Description

Address
300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.